Physician profile
Paul R Mitchell
NPI 1699728477
$4,741.80
in general payments reported to CMS, 2019-2025
22 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,242 · 2020: $885 · 2021: $756 · 2022: $322 · 2023: $300 · 2024: $114 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,744.87 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $981.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $746.90 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $219.58 | 2019-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $145.16 | 2020-2025 | Xtampza, Belbuca |
| Boston Scientific Corporation | $141.84 | 2019-2021 | |
| Pfizer INC. | $138.49 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $109.83 | 2019-2021 | |
| Painteq LLC | $81.29 | 2023 | Painteq |
| Nevro Corp. | $73.57 | 2019 | |
| Forte Bio-Pharma LLC | $56.05 | 2020-2021 | |
| Allergan, INC. | $52.95 | 2020 | |
| Mindray Ds USA, INC. | $48.53 | 2024 | Te X, Te7 Max |
| Trevena, INC. | $34.13 | 2021 | |
| Abbvie INC. | $27.50 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $23.57 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $21.40 | 2025 | |
| Shionogi INC | $20.66 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.85 | 2023 | Exparel, Zilretta, Iovera |
| Pacira Therapeutics, INC. | $19.17 | 2019 | |
| Medtronic, INC. | $18.24 | 2021 | |
| Sentynl Therapeutics, INC. | $16.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.